M&T Bank
ACOR

M&T Bank’s Acorda Therapeutics ACOR Stock Holding History

M&T Bank’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-86
Closed -$342K – 2213
2015
Q1 		$342K Sell
86
-8
-9% -$36.6K ﹤0.01% 1367
2014
Q4 		$460K Sell
94
-3
-3% -$12.9K ﹤0.01% 1254
2014
Q3 		$395K Buy
+97
New +$364K ﹤0.01% 1390

Other funds holding ACOR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

M&T Bank's ACOR Position: Q2 2015 in Review

M&T Bank sold out of Acorda Therapeutics (ACOR) in Q2 2015, closing a stake of 86 shares — an estimated $342K sold.

M&T Bank first reported a position in ACOR in Q3 2014 and held it in 3 quarters. The position peaked at $460K in Q4 2014. 170 funds tracked by Wall St. Rank hold ACOR as of Q2 2015.

  • M&T Bank reported no remaining Acorda Therapeutics position as of Q2 2015 after selling out during the quarter.
  • M&T Bank sold 86 Acorda Therapeutics shares in Q2 2015, an estimated $342K.
  • M&T Bank first reported a position in Acorda Therapeutics in Q3 2014 and held it in 3 quarters.
  • M&T Bank's Acorda Therapeutics position peaked at $460K in Q4 2014.
  • 170 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2015.

Based on M&T Bank's 13F filing for Q2 2015, filed 14 Aug 2015.